Sleep as a Mechanism of Change in Alcohol Use
ReTRAIN
1 other identifier
interventional
256
1 country
1
Brief Summary
This project aims to evaluate improvement of insomnia as a mechanism of improvement in alcohol use outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2024
CompletedFirst Posted
Study publicly available on registry
February 29, 2024
CompletedStudy Start
First participant enrolled
March 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 30, 2028
July 22, 2025
July 1, 2025
4.2 years
February 2, 2024
July 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Insomnia Symptoms
Assessed using Insomnia Severity Index (ISI). Response options range from 0 (not at all worried) to 4 (very much worried), with total scores ranging from 0 to 28 and higher scores indicating more severe insomnia.
Change from baseline to mid-treatment (week 4) to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups
Drinking quantity
Assessed using Timeline Followback and Daily Drinking Questionnaire. Typical weekly drinking quantity estimates will be summed to create a "drinks per week" total score, which will be used as our outcome variable.
Change from baseline to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups
Alcohol-related consequences
Assessed using the Drinker Inventory of Consequences (DrINC). Scores range from 0 to 120, with higher scores indicating more consequences. The common consequence subscale scores range from 0 to 18.
Change from baseline to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups
Secondary Outcomes (9)
Treatment willingness (alcohol)
Change from baseline to post-treatment (week 6)
Alcohol craving
Change from baseline to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups
Negative emotionality
Change from baseline to post-treatment (week 6) to 1-, 3-, and 6-month follow-ups
Response inhibition
Change from baseline to post (week 6) to 3-month follow-up
Working memory
Change from baseline to post (week 6) to 3-month follow-up
- +4 more secondary outcomes
Study Arms (2)
CBT-I
EXPERIMENTALIndividual Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered once a week for five (5) weeks.
Waitlist control
NO INTERVENTIONControl participants will receive CBT-I at the end of the study.
Interventions
Cognitive Behavioral Therapy for Insomnia (CBT-I). Participants assigned to the CBT-I condition will attend 1-hour individual sessions of CBT-I once a week for five weeks. Consistent with clinical guidelines (Schutte-Rodin, Broch, Buysse, Dorsey, \& Sateia, 2008), treatment will include stimulus control (e.g., limit use of bed to sleep or sexual activity, get out of bed if lying awake for more than 20 minutes), sleep restriction (limit time in bed to amount of time spent sleeping on a typical night), sleep hygiene (e.g., avoid exercise within 2 hours of bedtime, create cool and dark sleep environment), relaxation training, and cognitive restructuring.
Eligibility Criteria
You may qualify if:
- report heavy drinking in a typical week in the past month
- meet DSM-5 criteria for Alcohol Use Disorder
- meet DSM-5 and research diagnostic criteria for Insomnia Disorder
You may not qualify if:
- ≥50 years
- unable to provide informed consent
- report contraindications for CBT-I (mania or seizure disorder)
- moderate to severe sleep apnea that is untreated
- have symptoms requiring immediate clinical attention (e.g., psychosis, suicide plan)
- are already receiving behavioral treatment for insomnia or alcohol use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri-Columbia
Columbia, Missouri, 65212, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- PI Miller and study therapists will be blinded to assessment outcomes, and assessment RAs will be blinded to participant condition.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 2, 2024
First Posted
February 29, 2024
Study Start
March 2, 2024
Primary Completion (Estimated)
May 30, 2028
Study Completion (Estimated)
May 30, 2028
Last Updated
July 22, 2025
Record last verified: 2025-07